Skip to main content
Swing Capital

Apollo Hospitals Enterprise Ltd

NSE: APOLLOHOSP BSE: 508869Healthcare

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

₹8,060
52W: ₹6680 — ₹8250
PE 79.8 · Book ₹648 · +1144% vs book
Market Cap₹1,15,885 Cr
Stock P/E79.8Price to Earnings
ROCE16.4%Return on Capital
ROE15.1%Return on Equity
Div. Yield0.24%Face Value ₹5

Strengths

  • +Company has delivered good profit growth of 28.2% CAGR over last 5 years
  • +Company has been maintaining a healthy dividend payout of 18.9%

Weaknesses

  • −Stock is trading at 12.4 times its book value
  • −The company has delivered a poor sales growth of -3.49% over past five years.

Shareholding Pattern

Promoters28.02%
FIIs42.62%
DIIs22.76%
Public6.39%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters29.33%29.33%29.33%29.34%▲0.029.34%28.02%▼1.328.02%28.02%
FIIs43.92%45.37%▲1.445.27%▼0.142.74%▼2.543.49%▲0.844.2%▲0.743.54%▼0.742.62%▼0.9
DIIs21.13%19.94%▼1.219.97%▲0.022.29%▲2.321.34%▼0.921.12%▼0.221.5%▲0.422.76%▲1.3
Public5.38%5.12%▼0.35.21%▲0.15.41%▲0.25.61%▲0.26.43%▲0.86.71%▲0.36.39%▼0.3

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales1,8661,8241,8951,9372,1352,0552,0752,1682,3562,364
Expenses1,3871,3741,4441,4661,5951,5431,5541,6221,7631,770
Operating Profit479450450471540512521546593594
OPM %26%25%24%24%25%25%25%25%25%25%
Net Profit295263239252370342333307420384
EPS ₹20.518.2816.6117.5125.7123.7623.1921.3429.226.67

AI Insights

Revenue Trend

TTM revenue at ₹8,963Cr, up 9.3% YoY. OPM at 25%.

Debt Position

Borrowings at ₹3,133Cr. Debt-to-equity ratio: 0.34x. Healthy balance sheet.

Capex Cycle

CWIP at ₹390Cr (6% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 22.76% (+5.74pp change). FIIs: 42.62% (-5.31pp change). Promoters hold 28.02%.

Margin & Efficiency

ROCE improving from 13% (Mar 2014) to 16% (Mar 2025). Working capital days: 2.

Valuation

PE 79.8x with 16.4% ROCE. Price is 1144% above book value of ₹648. Dividend yield: 0.24%.

Recent Announcements